
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
VPS33B CRISPR/Cas9 KO Plasmid (m) | sc-433270 | 20 µg | $397.00 |
Vps33b encodes VPS33B, a Sec1/Munc18 family protein that functions as a core component of tethering and fusion machinery regulating endosomal–lysosomal trafficking. VPS33B cooperates with the VPS16/18/33/41 (HOPS/CORVET-related) network and the VPS33B–VIPAR complex to support vesicle docking, membrane fusion, and maintenance of epithelial polarity. In mouse cells, VPS33B activity contributes to cargo sorting, lysosome-related organelle biogenesis, and regulated secretion, linking it to broader pathways controlling membrane homeostasis and intracellular transport. Disruption of VPS33B-dependent trafficking has been associated with defects in polarized transport and platelet granule formation, providing a mechanistic framework for studying pathologies involving epithelial and hematopoietic dysfunction.
VPS33B CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Vps33b gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Vps33b together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Vps33b open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish VPS33B protein expression.
This CRISPR knockout system enables efficient generation of Vps33b-deficient cell models for investigation of VPS33B signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.